July 3, 2022
Quest Diagnostics Headquarters

Quest Diagnostics Board of Directors Compensation and Salary

Quest Diagnostics is a clinical laboratory company, headquartered in Secaucus, New Jersey. The company is listed on the NYSE with ticker name DGX. Steve Rusckowski is heading the company as the chief executive officer since May 2012. The company is engaged in the business of diagnostic testing services for cancer, infectious disease, cardiovascular disease, COVID-19 and more.  They have more than 47,000 employees in 2020.

So, let’s see information on Quest Diagnostics Board of Directors Compensation and Salary.

Quest Diagnostics Headquarters
Quest Diagnostics Headquarters

Quest Diagnostics Board of Directors Compensation and Salary 2019

Jenne K. Britell – Member of its Audit and Finance Committee

This board member earned total compensation US$58,250, cash paid US$58258,  and stock awards US$0.

Vicky B. Gregg – Former CEO of Blue Cross Blue Shield of Tennessee

This board member earned total compensation US$280,981, cash paid US$113,000, and stock awards US$167,981.

Jeffrey M. Leiden – Executive Chairman of Vertex Pharmaceuticals

This board member earned total compensation US$56,500, cash paid US$56,500,  and stock awards US$0.

Timothy L. Main – Chairman of the Board of Directors of Jabil Circuit, Inc.

This board member earned total compensation US$298,106, cash paid US$130,125, and stock awards US$167,981.

Denise M. Morrison – Retired President and Chief Executive Officer of Campbell Soup Company

This board member earned total compensation US$308,654, cash paid US$98,875, and stock awards US$209,779.

Gary M. Pfeiffer – Retired Senior Vice President and Chief Financial Officer of E.I. du Pont de Nemours and Company

This board member earned total compensation US$323,044, cash paid US$155,063, and stock awards US$167,981.

Timothy M. Ring – Retired Chairman and Chief Executive Officer of C. R. Bard, Inc.

This board member earned total compensation US$291,481, cash paid US$123,500, and stock awards US$167,981.

Daniel C. Stanzione – President Emeritus of Bell Laboratories

This board member earned total compensation US$340,544, cash paid US$172,563, and stock awards US$167,981.

Helen I. Torley – President and Chief Executive Officer of Halozyme Therapeutics, Inc.

She is working as a president and the CEO of Halozyme Therapeutics, Inc. This board member earned total compensation US$275,044, cash paid US$107,063, and stock awards US$167,981.

Gail R. Wilensky – Senior Fellow at Project HOPE

She is working as a senior fellow at PROJECT HOPE. This board member earned total compensation US$299,793, cash paid US$131,812, and stock awards US$167,981.